Facebook
X
LinkedIn
ForwardFundamentals of Anticancer Therapy Day 3 - Enduring Material - Credit offering period - June 26, 2026 - December 31, 2026
Cell Cycle Non-Specific Anti-cancer Therapy
Heather Kennihan MSN, RN, OCN
Case Studies
Target Audience
Identify function of cell cycle non-specific anti-cancer therapy drugs
Explain the mechanism of action for anti-tumor antibiotics, alkylating agents, and nitrosoureas
Discuss side effects of each drug
Additional Information
| Attachment | Size |
|---|---|
 AHNB21-206 (2-26)_ACT book_final.pdf | 21.74 MB |
| AHNB21-207 (2-26) ACT SOP Manual 2026_final (1).pdf | 2.22 MB |
| AHNB21-208 (2-26) ACT Workbook Template_final.pdf | 3.62 MB |
Course summary
- 2.25 AMA PRA Category 1 Credit™
- 2.25 Attendance
- 2.25 NCPD
Allegheny Health Network is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.
Accreditation: Allegheny General Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Allegheny General Hospital designates this enduring material activity for a maximum of 2.25 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
Allegheny Health Network is approved as a provider for nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation
Available Credit
- 2.25 AMA PRA Category 1 Credit™
- 2.25 Attendance
- 2.25 NCPD
Allegheny Health Network is approved as a provider of nursing continuing professional development by Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.